Drug-induced Hypomagnesemia (TRPM7)

From Magnesium
Revision as of 09:04, 27 January 2024 by Ossip Groth (talk | contribs)


38222324 PDF 2024. Multiple electrolyte disorders triggered by proton pump inhibitor-induced hypomagnesemia: Case reports with a mini-review of the literature.Template:38222324
36110961 PDF 2022. Mass spectrometric analysis of TRPM6 and TRPM7 from small intestine of omeprazole-induced hypomagnesemic rats.Template:36110961
34714373 PDF 2022. Proton pump inhibitors and osteoporosis risk: exploring the role of TRPM7 channel.Template:34714373
23051182 PDF 2012. Modeling and simulation of the effect of proton pump inhibitors on magnesium homeostasis. 1. Oral absorption of magnesium.Template:23051182
25138239 PDF 2015. Hypomagnesaemia associated with long-term use of proton pump inhibitors.Template:25138239
23538697 PDF 2013. Proton pump inhibitors and hypomagnesemia: a rare but serious complication.Template:23538697
35836357 PDF 2022. Severe Electrolyte Disturbances Due to Proton Pump Inhibitor Therapy: An Underrecognized Problem with Potentially Severe Sequelae.Template:35836357
35652564 PDF 2022. Mechanisms of proton pump inhibitor-induced hypomagnesemia.Template:35652564
24414180 PDF 2014. Lansoprazole-induced hypomagnesaemia.Template:24414180
23664547 PDF 2013. Out-of-hospital use of proton pump inhibitors and hypomagnesemia at hospital admission: a nested case-control study.Template:23664547

36983271 PDF 2023. Proton Pump Inhibitors and Risk of Chronic Kidney Disease: Evidence from Observational Studies.'

Template:36983271


33442177 PDF 2020. The Perilous PPI: Proton Pump Inhibitor as a Cause of Clinically Significant Hypomagnesaemia.Template:33442177
31817776 PDF 2019. Proton-Pump Inhibitors and Hypomagnesaemia in Kidney Transplant Recipients.Template:31817776
31035385 PDF 2019. Magnesium and Drugs.Template:31035385
28078056 PDF 2016. Proton pump inhibitor-induced hypomagnesaemia and hypocalcaemia: case review.Template:28078056
26885127 PDF 2015. Proton pump inhibitors use in hemodialysis patients and serum magnesium levels.Template:26885127
26130997 PDF 2015. 'Lemonade Legs': Why do Some Patients Get Profound Hypomagnesaemia on Proton-Pump Inhibitors?Template:26130997
25138239 PDF 2015. Hypomagnesaemia associated with long-term use of proton pump inhibitors.Template:25138239
31689852 PDF 2019. Proton pump inhibitors and hypomagnesemia: A meta-analysis of observational studies.Template:31689852
30921222 PDF 2019. Does the use of proton pump inhibitors increase the risk of hypomagnesemia: An updated systematic review and meta-analysis.Template:30921222
34278747 PDF 2021. An overview of diagnosis and management of drug-induced hypomagnesemia.Template:34278747
32130255 PDF 2020. Omeprazole use and risk of chronic kidney disease evolution.Template:32130255
25268962 PDF 2014. Proton pump inhibitors and hospitalization with hypomagnesemia: a population-based case-control study.Template:25268962
37791144 PDF 2023. Osmotic Demyelination Syndrome in a Normonatremic Patient Under Treatment With Proton Pump Inhibitors.Template:37791144
37109245 PDF 2023. Effect of Long-Term Proton Pump Inhibitor Use on Blood Vitamins and Minerals: A Primary Care Setting Study.Template:37109245
36794273 PDF 2023. Proton-pump inhibitor use amongst patients with severe hypomagnesemia.Template:36794273
36769401 PDF 2023. Calcineurin-Inhibitor-Induced Hypomagnesemia in Kidney Transplant Patients: A Monocentric Comparative Study between Sucrosomial Magnesium and Magnesium Pidolate Supplementation.Template:36769401
36514145 PDF 2022. Monitoring of serum magnesium levels during long-term use of proton pump inhibitors in elderly japanese patients: is it really necessary or not?Template:36514145
35178215 PDF 2022. Relationship between long-term use of proton pump inhibitor (PPI) and hypomagnesemia in patients with gastroesophageal reflux disease.Template:35178215
34466238 PDF 2021. Seizure and delirium secondary to carboplatin and pantoprazole therapy-induced hypomagnesemia in a cancer patient.Template:34466238
34093176 PDF 2021. Proton Pump Inhibitor and Tacrolimus Uses are Associated With Hypomagnesemia in Connective Tissue Disease: a Potential Link With Renal Dysfunction and Recurrent Infection.Template:34093176
32231419 PDF 2020. Effect of prolonged omeprazole administration on segmental intestinal Mg(2+) absorption in male Sprague-Dawley rats.Template:32231419

30996187 PDF 2019. Proton-pump Inhibitor-induced Severe Hypomagnesemia and Hypocalcemia are Clinically Masked by Thiazide Diuretic.'

Template:30996187


30153299 PDF 2018. Effect of proton pump inhibitors on sympathetic hyperinnervation in infarcted rats: Role of magnesium.Template:30153299
29969455 PDF 2018. Proton pump inhibitor as an independent factor of progression of abdominal aortic calcification in patients on maintenance hemodialysis.Template:29969455
29799851 PDF 2018. Prevalence and outcomes of proton pump inhibitor associated hypomagnesemia in chronic kidney disease.Template:29799851
29731714 PDF 2018. Proton Pump Inhibitors and Serum Magnesium Levels in Patients With Torsades de Pointes.Template:29731714
29725641 PDF 2018. Proton Pump Inhibitor Usage and the Risk of Mortality in Hemodialysis Patients.Template:29725641
30766253 PDF 2017. Review of the Long-Term Effects of Proton Pump Inhibitors.Template:30766253
26981439 PDF 2016. Proton-pump inhibitor-induced hypomagnesemia: Current research and proposed mechanisms.Template:26981439
26613375 PDF 2016. Proton pump inhibitor associated hypomagnasaemia - a cause for concern?Template:26613375
25394217 PDF 2014. The association between the use of proton pump inhibitors and the risk of hypomagnesemia: a systematic review and meta-analysis.Template:25394217
24175253 PDF 2012. Proton pump inhibitor-induced hypomagnesemia: A new challenge.Template:24175253
23847429 PDF 2013. Effects of proton pump inhibitors and electrolyte disturbances on arrhythmias.Template:23847429

21472124 PDF 2011. Omeprazole decreases magnesium transport across Caco-2 monolayers.'

Template:21472124


34275986 PDF 2022. Convulsive Seizure Due to Hypomagnesemia Caused by Short-term Vonoprazan Intake.Template:34275986
34176835 PDF 2022. Severe Hypomagnesemia Associated with the Long-term Use of the Potassium-competitive Acid Blocker Vonoprazan.Template:34176835